Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News

Author's Avatar
May 06, 2025
Article's Main Image

On May 6, 2025, Baird analyst Catherine Ramsey maintained the "Outperform" rating for Twist Bioscience (TWST, Financial), a biotechnology firm renowned for its synthetic DNA products. Despite keeping the current rating consistent, Ramsey has lowered the price target for the stock.

The revised price target for Twist Bioscience (TWST, Financial) has been adjusted to $44.00 USD from the previous target of $54.00 USD. This adjustment represents an 18.52% decrease from the prior target. It is important to note that the decision to maintain the "Outperform" rating reflects continued confidence in the company's performance potential despite the updated price target.

The adjustment in the price target by Baird comes amidst various market dynamics and industry considerations, and is a reminder for investors to take stock movements and analyst guidance into account when evaluating their positions in Twist Bioscience (TWST, Financial).

Wall Street Analysts Forecast

1919740599599263744.png

Based on the one-year price targets offered by 11 analysts, the average target price for Twist Bioscience Corp (TWST, Financial) is $51.47 with a high estimate of $62.00 and a low estimate of $44.00. The average target implies an upside of 43.25% from the current price of $35.93. More detailed estimate data can be found on the Twist Bioscience Corp (TWST) Forecast page.

Based on the consensus recommendation from 13 brokerage firms, Twist Bioscience Corp's (TWST, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) in one year is $59.61, suggesting a upside of 65.91% from the current price of $35.93. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Twist Bioscience Corp (TWST) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.